Listen to this article

Zimmer Holdings (NYSE: ZMH), an Indiana-based manufacturer of orthopedic reconstructive implants and trauma products, has said that its previously announced acquisition of Allendale’s Implex will be an all-cash transaction.In November, Zimmer announced plans to buy Implex, a privately held medical technology developer, for $89 million in stock and $19 million in cash held in escrow.In a press release Thursday, Zimmer said shares of Implex stock will be converted into the right to receive cash having an aggregate value of approximately $108 million at closing and additional cash earn-out payments that are contingent on growth of Implex product sales through 2006.The acquisition is expected to close in April of 2004. The boards of directors of both companies have approved the merger, which is subject to approval by Implex’s shareholders and other customary closing conditions. Implex has called a special meeting of its shareholders to be held on March 26 in order to approve the transaction. On closing of the deal, Implex will become a wholly owned subsidiary of Zimmer.